Quantum Discovery

Quantum Discovery Labs is a technology based drug discovery company. We develop a unique computational drug discovery platform (QUANTUM), provide drug discovery services, and pursue our own in-house drug discovery projects searching for novel compounds with anti-bacterial, anti-viral and anti-cancer efficacy.

Quantum@linkedin.com
Contacts: office@q-pharm.com or comment any post on the site. You are welcome!

Quantum on Google+

Categories

• absorbtion (3)
• active transport (2)
• ADME (4)
• antibiotics (2)
• antiviral (6)
• bioavailability (3)
• cancer (5)
• cardiotoxicity (1)
• collaboration (13)
• compound libraries (1)
• COPD (1)
• docking (13)
• drug design (8)
• drug discovery platform (1)
• druglikeness (4)
• false positive (3)
• flue (4)
• Generalized Born (15)
• GPCR (1)
• HERG (6)
• HIV (3)
• HIV-1 integrase (1)
• HSV (1)
• human neutrophil elastase (1)
• IC50 (18)
• inflammation (3)
• influenza (3)
• kinase (1)
• LD50 (2)
• logP (1)
• matrix proteins (2)
• mechanism of action exploration (2)
• MRDD (3)
• new therapeutic uses (1)
• oncology (4)
• openbabel (3)
• PDK1 (1)
• polar liquid (17)
• publications (12)
• q-Mol (1)
• QSAR (1)
• Quantum Software (11)
• RecA (1)
• scoring (1)
• selectivity (3)
• solvation energy (19)
• ss DNA (1)
• talk (5)
• toxicity (7)
• trombine (2)
• tuberculosis (4)
• Uncategorized (5)
• video (3)
• water (20)

Recent comments

• Nbarnes25 on Quantum Discovery Services
• New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1 on Influenza matrix M1 protein inhibitors show promising in-vivo efficacy
• Anonymous on Water polarization and density profiles at a gas-liquid interface
• Anonymous on New inhibitors of RecA (bacterial SOS response system) identified.
• J G Frey on Molecular polarization on a polar liquid interface: the structure of a water surface